Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, dox- azosin and tamsulosin in healthy normotensive men. J Urol. 2004; 172:1935 40. 496. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56: 320 8. 497. Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18:441 9. 498. Schaefer EJ, Lamon-Fava S, Ausman LM, et al. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr. 1997;65:823 30. 499. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 1995;15:1079 85. 500. Yu-Poth S, Zhao G, Etherton T, et al. Effects of the National Choles- terol Education Program s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a metaanalysis. Am J Clin Nutr. 1999;69:632 46. 501. Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437 45. 502. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251: 351 64. 503. Deleted in proof. 504. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245 55. 505. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, anti- oxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583 92. 506. 